Navigation Links
The Conferences Forum Launches Patients as Partners Event

New York, NY (PRWEB) November 25, 2013

The Conference Forum is proud to present Patients as Partners with CISCRP’s founder Ken Getz as conference chair, along with an exciting speaking faculty representing industry, advocacy, academia, patients and the FDA. Together, they address the latest strategies, technologies and policies to vastly improve the patient experience in clinical trials. The conference addresses how sponsors of clinical trials can realistically partner with patients and how patients can partner with sponsors to meet the demands of:

  • Evolving Science: Personalized Medicine
  • Higher Quality Data
  • Lower Dropout Rates
  • New Therapies Faster to Market

Patients as Partners takes a broad view of the patient experience and how we engage with patients across the entire clinical trial continuum. This includes early research, patient-centric protocol design, recruitment, retention, engagement, and communicating results with patients acting as ambassadors and educators.

“If you put the patient lens in front, you start to come up with some really solid answers and solutions.” - Jeffrey Kasher, PhD, Eli Lilly

The conference is designed for clinical trial executives in pharma and biotech, directors in patient advocacy and academia, and service providers who are looking to incorporate the patient perspective throughout the clinical trial process, valuing patients and treating them as partners, ultimately leading to more successful clinical trials. Take advantage of the first early bird and register by December 20th.

Speaking Faculty:

  •     Annette Bar-Cohen, MA, MPH, Executive Director, Center for NBCC Advocacy Training
        National Breast Cancer Coalition
  •     Lily Cappelletti, Associate Director, Research Partnerships, The Michael J. Fox
        Foundation for Parkinson’s Research
  •     Lama Chahine, MD, Instructor of Neurology, Parkinson's Disease and Movement
        Disorders Center,University of Pennsylvania
  •     Jacqueline Cole, Clinical Operations Portfolio Management, Oncology, Eli Lilly
  •     Maria Corvez, Clinical Research Manager II, Millennium Pharmaceuticals
  •     Iris Culbert, Senior Clinical Project Manager, Global Clinical Operations, Teva
  •     Daniel Davis, Oncology Business Unit Advisor, Eli Lilly
  •     Victoria DiBiaso, Head of Investigator & Patient Networks, Sanofi Genzyme
  •     Adam Dole, Presidential Innovation Fellow, The White House*
  •     Ken Getz, MBA, Director of Sponsored Research / Founder, Tufts CSDD / CISCRP
  •     Stuart Horowitz, PhD, MBA, President, Global Professional Services, WIRB Copernicus
  •     Andreas Koester, MD, PhD, VP, Clinical Trial Innovation & External Alliances, Janssen
  •     Craig Lipset, MBA, Head of Clinical Innovation, R&D, Pfizer
  •     Debra Lounsbury, Principal Scientist, BioMarin
  •     Kimberly McCleary, Director, Strategic Initiatives, FasterCures
  •     Nariman Nasser,Digital Strategist, Genentech
  •     Bray Patrick-Lake, BS, MFS, Director of Stakeholder Engagement, Clinical Trials
        Transformation Initiative
  •     Christine Pierre, President, Society for Clinical Research Sites
  •     Tomasz Sablinski, MD, PhD, Founder & CEO, Transparency Life Sciences
  •     Jean Slutsky, PA, MSPH, Director, Center for Outcomes and Evidence Agency for
        Healthcare Research and Quality
  •     Komathi Stem, Senior Director, Product Development, Innovation Lead, Genentech
  •     Andrea Tan, Operations Research Analyst, Office of Strategic Programs, CDER, FDA
  •     Ronnie Todaro, Vice President, National Programs / Co-Chair, Parkinson’s Disease
        Foundation / CTTI Patient Leadership Council
  •     Jennifer Wulff, Director, Clinical Innovation, Pfizer*
  •     Anthony Yanni, Head of Patient Value & Strategy, Sanofi Genzyme

*Invited speakers

About The Conference Forum
The Conference Forum has a very specific focus – developing specialized events both public and private as well as research groups and advisory boards for professionals in the life science industry. Its mission is to create the best content in an ideal forum for the exchange of ideas among peers and networking for Pharmaceutical and Biotech professionals. See more at:

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dyadic International To Present At Two Major Conferences In December 2013
2. Aratana Therapeutics to Present at Two Upcoming Investor Conferences
3. Bone Biologics Investor Presentation Now Available for On-demand Viewing at
4. BioLight Israeli Life Sciences Investments Ltd. to Webcast, Live, at on September 12th
5. Trovagene to Present at Two Healthcare Conferences
6. ANP to present at and attend major US investment, partnering and industry conferences
7. SPIE Leaders Commend OMB Support for Travel to Scientific Conferences, Say Funding is Also Needed
8. Metabolix Executives to Present at Leading Industry Conferences
9. Heptares to Present at Upcoming Biotech Industry Conferences
10. Sigma-Aldrich Corporation Presentations At Three Upcoming Conferences To Be Webcast Live
11. Verenium To Present At Two Upcoming Conferences
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... innovative medical technologies, services and solutions to the healthcare market. The company's primary ... various distribution, manufacturing, sales and marketing strategies that are necessary to help companies ...
(Date:6/24/2016)... discussions on a range of subjects including policies, debt and ... Poloz. Speaking at a lecture to the Canadian ... to the country,s inflation target, which is set by both ... "In certain areas there needs to be ... why not sit down and address strategy together?" ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced ... this eBook by providing practical tips, tools, and strategies for clinical researchers. , ...
(Date:6/23/2016)... , June 23, 2016 A person commits ... the crime scene to track the criminal down. ... U.S. Food and Drug Administration (FDA) uses DNA evidence to ... Sound far-fetched? It,s not. The FDA has ... to support investigations of foodborne illnesses. Put as simply as ...
Breaking Biology Technology:
(Date:3/31/2016)... March 31, 2016   ... or the "Company") LegacyXChange is excited to ... its soon to be launched online site for trading ... ) will also provide potential shareholders a sense ... technology to an industry that is notorious for fraud. ...
(Date:3/29/2016)... , March 29, 2016 ... "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to ... ink used in a variety of writing instruments, ensuring ... of originally created collectibles from athletes on LegacyXChange will ... analysis of the DNA. Bill Bollander ...
(Date:3/22/2016)... , March 22, 2016 ... report "Electronic Sensors Market for Consumer Industry by Type ... Others), Application (Communication & IT, Entertainment, Home ... Global Forecast to 2022", published by MarketsandMarkets, ... expected to reach USD 26.76 Billion by ...
Breaking Biology News(10 mins):